ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 111 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is 3.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,474,000 | -23.5% | 649,348 | +0.6% | 0.00% | -33.3% |
| Q3 2016 | $17,603,000 | +93.8% | 645,740 | +2.3% | 0.00% | +200.0% |
| Q2 2016 | $9,081,000 | -1.5% | 631,062 | -1.6% | 0.00% | -50.0% |
| Q1 2016 | $9,219,000 | -24.1% | 641,578 | +13.5% | 0.00% | 0.0% |
| Q4 2015 | $12,151,000 | +48.1% | 565,424 | +11.5% | 0.00% | +100.0% |
| Q3 2015 | $8,206,000 | -25.4% | 507,141 | +19.0% | 0.00% | -50.0% |
| Q2 2015 | $10,999,000 | +16.1% | 426,143 | +1.3% | 0.00% | +100.0% |
| Q1 2015 | $9,470,000 | +69.4% | 420,869 | +44.5% | 0.00% | 0.0% |
| Q4 2014 | $5,591,000 | +6.8% | 291,331 | +19.6% | 0.00% | 0.0% |
| Q3 2014 | $5,234,000 | -27.2% | 243,689 | -11.9% | 0.00% | 0.0% |
| Q2 2014 | $7,193,000 | +203.8% | 276,653 | +154.8% | 0.00% | – |
| Q1 2014 | $2,368,000 | +80.4% | 108,570 | +0.9% | 0.00% | – |
| Q4 2013 | $1,313,000 | -13.1% | 107,630 | -4.5% | 0.00% | – |
| Q3 2013 | $1,511,000 | +84.0% | 112,713 | +11.4% | 0.00% | – |
| Q2 2013 | $821,000 | – | 101,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
| Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
| Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
| LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
| Miura Global Management | 435,000 | $8,348,000 | 0.63% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
| Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
| BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
| Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
| FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |